We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-4.85%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.16B
AUM Growth
-$97.2M
(-7.7%)
Cap. Flow
+$7.64M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
55.45%
Holding
63
New
12
Increased
17
Reduced
17
Closed
13
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
+$27.1M |
| 2 |
Penumbra
PEN
|
+$24.6M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$24.3M |
| 4 |
Xencor
XNCR
|
+$24M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$20.5M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$39.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$23.3M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$21.6M |
| 4 |
ELGX
Endologix Inc
ELGX
|
+$20.8M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$20.8M |
Sector Composition
| 1 | Healthcare | 95.37% |
| 2 | Financials | 0.92% |
| 3 | Communication Services | 0.62% |
| 4 | Consumer Staples | 0.41% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $146M | 12.59% |
16,618,776
-39,296
| -0.2% | -$289K |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $80.3M | 6.92% |
1,520,904
-260,566
| -15% | -$15.7M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $72M | 6.2% |
1,620,355
-429,630
| -21% | -$15.1M |
|
|
4
Penumbra
PEN
$12.5B
| $66.4M | 5.72% |
1,040,208
+367,290
| +55% | +$24.6M |
|
|
FOLD
5
DELISTED
Amicus Therapeutics
FOLD
| $61.3M | 5.28% |
12,331,130
-420,406
| -3% | -$2.91M |
|
|
ARIA
6
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $47.7M | 4.12% |
3,838,376
+1,699,905
| +79% | +$20.5M |
|
7
Incyte
INCY
$23B
| $45.3M | 3.91% |
451,987
-145,651
| -24% | -$14.2M |
|
8
Molina Healthcare
MOH
$12.1B
| $43.7M | 3.77% |
805,546
+27,386
| +4% | +$1.5M |
|
|
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $40.9M | 3.53% |
366,068
-179,854
| -33% | -$21.6M |
|
|
10
Puma Biotechnology
PBYI
$425M
| $39.6M | 3.41% |
1,290,140
+627,854
| +95% | +$27.1M |
|
11
Atara Biotherapeutics
ATRA
$76.7M
| $37.9M | 3.27% |
106,838
+25,973
| +32% | +$11M |
|
|
NDRM
12
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $34.6M | 2.99% |
1,560,819
+755,573
| +94% | +$14.1M |
|
13
Prothena Corp
PRTA
$448M
| $32.2M | 2.77% |
653,725
-47,934
| -7% | -$2.64M |
|
14
Agios Pharmaceuticals
AGIO
$2.36B
| $30.8M | 2.66% |
738,451
+551
| +0.1% | +$28.9K |
|
15
Centene
CNC
$33B
| $29.2M | 2.52% |
1,033,196
+105,042
| +11% | +$3.1M |
|
|
16
Xencor
XNCR
$1.1B
| $26.2M | 2.26% |
+996,100
| New | +$24M |
|
|
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $25.4M | 2.19% |
1,701,049
+269,930
| +19% | +$3.79M |
|
18
Wave Life Sciences
WVE
$1.14B
| $24.9M | 2.15% |
951,712
+249,890
| +36% | +$8.13M |
|
|
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
| $23.3M | 2.01% |
+338,800
| New | +$24.3M |
|
|
NSTG
20
DELISTED
NanoString Technologies, Inc.
NSTG
| $20.9M | 1.8% |
937,957
-299,478
| -24% | -$6.42M |
|
|
ALDR
21
DELISTED
Alder Biopharmaceuticals
ALDR
| $19.1M | 1.65% |
920,550
+218,011
| +31% | +$5.67M |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $18.9M | 1.63% |
260,380
+33,113
| +15% | +$2.83M |
|
23
Charles River Laboratories
CRL
$10.9B
| $18.8M | 1.62% |
247,107
+120,001
| +94% | +$9.11M |
|
|
CMRX
24
DELISTED
Chimerix, Inc.
CMRX
| $15.4M | 1.33% |
3,345,959
+131,013
| +4% | +$619K |
|
|
BOLD
25
DELISTED
Audentes Therapeutics, Inc
BOLD
| $15.2M | 1.31% |
832,736
-83,890
| -9% | -$1.45M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO